VEGFA and cancer: Tumour angiogenesis is prevented by mTOR inhibitors through two mechanisms: i) decreased synthesis and release of angiogenic growth factors (especially VEGF) from the cancer cells and ii) blocked growth by the reduction of vascular cell survival.